FI97551B - Analysmetod, reagenskomposition och användning därav för glukosbestämning - Google Patents
Analysmetod, reagenskomposition och användning därav för glukosbestämning Download PDFInfo
- Publication number
- FI97551B FI97551B FI915020A FI915020A FI97551B FI 97551 B FI97551 B FI 97551B FI 915020 A FI915020 A FI 915020A FI 915020 A FI915020 A FI 915020A FI 97551 B FI97551 B FI 97551B
- Authority
- FI
- Finland
- Prior art keywords
- nicotinamide
- glucose
- phenazine
- whole blood
- nad
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 38
- 239000008103 glucose Substances 0.000 title claims abstract description 38
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000004458 analytical method Methods 0.000 title description 6
- 210000004369 blood Anatomy 0.000 claims abstract description 37
- 239000008280 blood Substances 0.000 claims abstract description 37
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims abstract description 26
- 230000002949 hemolytic effect Effects 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 16
- 102000020006 aldose 1-epimerase Human genes 0.000 claims abstract description 12
- 108091022872 aldose 1-epimerase Proteins 0.000 claims abstract description 12
- 229930182490 saponin Natural products 0.000 claims abstract description 11
- 150000007949 saponins Chemical class 0.000 claims abstract description 11
- 235000017709 saponins Nutrition 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 10
- 102000015439 Phospholipases Human genes 0.000 claims abstract description 9
- 108010064785 Phospholipases Proteins 0.000 claims abstract description 9
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims abstract description 8
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 8
- YTEJSAFVYHDCSN-UHFFFAOYSA-K zinc;benzo[a]phenoxazin-9-ylidene(dimethyl)azanium;trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Zn+2].C1=CC=C2C(N=C3C=CC(C=C3O3)=[N+](C)C)=C3C=CC2=C1 YTEJSAFVYHDCSN-UHFFFAOYSA-K 0.000 claims abstract description 8
- CXONXVMMINSQBV-NNYOXOHSSA-N (2r,3r,4s,5r)-5-[[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2-(3-carbamothioylpyridin-1-ium-1-yl)-4-hydroxyoxolan-3-olate Chemical compound NC(=S)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)[O-])=C1 CXONXVMMINSQBV-NNYOXOHSSA-N 0.000 claims abstract description 7
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 claims abstract description 7
- VDJKJPMLWJWQIH-UHFFFAOYSA-M 5-ethylphenazin-5-ium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.C1=CC=C2[N+](CC)=C(C=CC=C3)C3=NC2=C1 VDJKJPMLWJWQIH-UHFFFAOYSA-M 0.000 claims abstract description 7
- CNPRPOBKEGWPEX-UHFFFAOYSA-N 7h-purine;pyridine-3-carboxamide Chemical compound C1=NC=C2NC=NC2=N1.NC(=O)C1=CC=CN=C1 CNPRPOBKEGWPEX-UHFFFAOYSA-N 0.000 claims abstract description 7
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims abstract description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 238000002798 spectrophotometry method Methods 0.000 claims abstract description 7
- 150000004043 trisaccharides Chemical class 0.000 claims abstract description 7
- HWODJSXQTMRQQL-UHFFFAOYSA-N 2-methyl-7h-purine;pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.CC1=NC=C2NC=NC2=N1 HWODJSXQTMRQQL-UHFFFAOYSA-N 0.000 claims abstract description 6
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 claims abstract description 6
- 230000005540 biological transmission Effects 0.000 claims abstract description 6
- -1 thio-NADP Chemical compound 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 8
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 8
- LQLUCEWHNRKKLL-UHFFFAOYSA-N 2-(chloromethyl)-7h-purine;pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.ClCC1=NC=C2NC=NC2=N1 LQLUCEWHNRKKLL-UHFFFAOYSA-N 0.000 claims description 4
- 238000011002 quantification Methods 0.000 claims description 3
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 claims description 2
- MPZLSODAWKMAII-UHFFFAOYSA-N 2-chloro-8-methyl-7h-purine;pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.ClC1=NC=C2NC(C)=NC2=N1 MPZLSODAWKMAII-UHFFFAOYSA-N 0.000 abstract 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 abstract 1
- 239000002824 redox indicator Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 34
- 238000005259 measurement Methods 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000007430 reference method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 101100080807 Drosophila melanogaster mt:ND2 gene Proteins 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N Glycolaldehyde Chemical compound OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 108010020056 Hydrogenase Proteins 0.000 description 2
- 101150016680 MT-ND2 gene Proteins 0.000 description 2
- 102100028488 NADH-ubiquinone oxidoreductase chain 2 Human genes 0.000 description 2
- 101150102231 ND2 gene Proteins 0.000 description 2
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- KMEBCRWKZZSRRT-UHFFFAOYSA-N 2-methyl-7h-purine Chemical compound CC1=NC=C2NC=NC2=N1 KMEBCRWKZZSRRT-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 108010036176 Melitten Proteins 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012482 calibration solution Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000007357 dehydrogenase reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- VDXZNPDIRNWWCW-UHFFFAOYSA-N melitten Chemical compound NCC(=O)NC(C(C)CC)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- UMWKZHPREXJQGR-XOSAIJSUSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]decanamide Chemical compound CCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO UMWKZHPREXJQGR-XOSAIJSUSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- YZYDOFGGDSDUPX-UHFFFAOYSA-M sodium;carbonic acid;chloride Chemical compound [Na+].[Cl-].OC(O)=O YZYDOFGGDSDUPX-UHFFFAOYSA-M 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Claims (5)
1. Metod för kvantitativ bestämnlng av totalglukos 1 outspätt helblod, kännetecknad därav, att 5 ett prov av outspätt helblod bringas i kontakt med ett reagens i torr from som innefattar: glukosdehydrogenas (GDH); ett eller flera av ämnena diaforas, fenazin-metosulfat, fenazinetosulfat, fenazinfenosulfat och Meldo- 10 la blue; ett eller flera av ämnena NAD, NADP, tio-NAD, tio-NADP, nikotinamidpurin-dinukleotid, nikotinamid-metylpu-rin-dinukleotid, nikotinamid-2-klor-metylpurin-dinukleo-tid; 15 ett eller flera av de hemolyserande ämnena fosfoli pas, hemolyserande saponlner samt föreningar mellan hydro-fila mono-, di- eller trisackarider och alifatiska kolvä-ten med 10-16 kolatomer; en redoxindikatorfärg, som är ett tetrazoliumsalt; 20 och eventuellt mutarotas; samt att en färgförändring som uppkommit genom reagensets reaktion med glukos i det outspädda helblodet mäts med trans-missionspektrofotometri.
2. Metod enligt patentkrav 1, känneteck nad därav, att provet av helblod ges en volym pä mind-re än 20 mikroliter.
3. Reagenskompositiön för kvantitativ bestämning av totalglukos i outspätt helbold, kännetecknad 30 därav, att den föreligger i torr form och att den inne-fattar: glukosdehydrogenas (GDH); ett eller flera av ämnena diaforas, fenazinmetosul-fat, fenazinetosulfat, fenazinfenosulfat och Meldola blue; 35 ett eller flera av ämnena NAD, NADP, tio-NAD, tio- NADP, nikotinamidpurin-dinukleotid, nikotinamid-metylpu- 97551 15 rin-dinukleotid, nikotinamid-2-klor-6-metylpurin-dinuk-leotld; ett eller flera av de hemolyserande ämnena fosfoli-pas, hemolyserade saponiner samt föreningar me11an hydro-5 fila mono-, dl- eller trisackarider och alifatiska kolvä-ten med 10 - 16 kolatomer; en redoxinidikatorfärg, som är ett tetrazoliumsalt; och eventuellt mutarotas.
4. Reagenskomposition enligt patentkrav 3, k ä n - netecknad därav, att den innefattar: glukosdehydrogenas, diaforas, NAD, 15 ett eller flera saponin, ett tetrazoliumsalt, och eventuellt mutarotas.
5. Användning av en reagenskomposition, vilken komposition innefattar: 20 glukosdehydrogenas (GDH); ett eller flera av ämnena diaforas, fenazinmetosul-fat, fenazinetosulfat, fenazinfenosulfat och Meldola blue; ett eller flera av ämnena NAD, NADP, tio-NAD, tio-NADP, nikotinamidpurin-dinukleotid, nikotinamid-metylpu-25 rin-dinukleotid, nikotinamid-2-klor-metylpurin-dinukleo- tid; ett eller flera av de hemolyserande ämnena fosfolipas, hemolyserande saponiner samt föreningar mellan hydro-fila mono-, di- eller trisackarider och alifatiska kolvä-30 ten med 10-16 kolatomer; en redoxinidikatorfärg, som är ett tetrazoliumsalt; och eventuellt mutarotas, och vilken komposition föreligger i torr form, för utför-35 ande av en kvantitativ bestäming av totalglukos i outspätt helblod med hjälp av transmissionsspektrofotometri.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8901515 | 1989-04-25 | ||
| SE8901515A SE466158B (sv) | 1989-04-25 | 1989-04-25 | Analysmetod foer glukosbestaemning i helblod |
| SE9000272 | 1990-04-24 | ||
| PCT/SE1990/000272 WO1990012889A1 (en) | 1989-04-25 | 1990-04-24 | Method of analysis, reagent composition and use thereof for glucose determination |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI915020A0 FI915020A0 (sv) | 1991-10-24 |
| FI97551B true FI97551B (sv) | 1996-09-30 |
| FI97551C FI97551C (sv) | 1997-01-10 |
Family
ID=20375802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI915020A FI97551C (sv) | 1989-04-25 | 1991-10-24 | Analysmetod, reagenskomposition och användning därav för glukosbestämning |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5278047A (sv) |
| EP (1) | EP0470201B1 (sv) |
| JP (1) | JPH0734757B2 (sv) |
| KR (1) | KR960001139B1 (sv) |
| AT (1) | ATE122102T1 (sv) |
| AU (1) | AU637612B2 (sv) |
| BR (1) | BR9007339A (sv) |
| CA (1) | CA2053315C (sv) |
| DE (1) | DE69019149T2 (sv) |
| DK (1) | DK0470201T3 (sv) |
| ES (1) | ES2071821T3 (sv) |
| FI (1) | FI97551C (sv) |
| LT (1) | LT3136B (sv) |
| LV (1) | LV10122B (sv) |
| NO (1) | NO300853B1 (sv) |
| RU (1) | RU2050546C1 (sv) |
| SE (1) | SE466158B (sv) |
| WO (1) | WO1990012889A1 (sv) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE29580485U1 (de) * | 1994-09-08 | 1997-05-28 | Lindab Ab, Bastad | Vorrichtung zum Verbinden von Rohrabschnitten |
| DK9500486U3 (da) * | 1995-12-18 | 1997-04-11 | Lindab As | Indretning til sammenkobling af rørstykker |
| EP1082006B1 (en) | 1998-05-26 | 2006-02-01 | Lifecell Corporation | Cryopreservation of human red blood cells |
| US6077660A (en) * | 1998-06-10 | 2000-06-20 | Abbott Laboratories | Diagnostic assay requiring a small sample of biological fluid |
| US6312888B1 (en) | 1998-06-10 | 2001-11-06 | Abbott Laboratories | Diagnostic assay for a sample of biological fluid |
| US6656697B1 (en) * | 1998-09-28 | 2003-12-02 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
| US5902731A (en) * | 1998-09-28 | 1999-05-11 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
| LT4605B (lt) | 1999-04-07 | 2000-01-25 | Biochemijos Institutas | Fermentinis gliukozės sensorius ir jo gavimo būdas |
| RU2163722C2 (ru) * | 1999-05-12 | 2001-02-27 | Рязанский государственный медицинский университет им. акад. И.П. Павлова | Способ определения моносахаридов в сыворотке крови |
| US6485923B1 (en) | 2000-02-02 | 2002-11-26 | Lifescan, Inc. | Reagent test strip for analyte determination having hemolyzing agent |
| AU2001243542A1 (en) * | 2000-03-28 | 2001-10-08 | Lifescan, Inc. | Reagent systems for detecting the presence of a reduced cofactor in a sample and methods for using the same |
| US6368818B1 (en) * | 2000-10-12 | 2002-04-09 | Qingzhong Kong | Methods and compositions for the visualization of cellular organelles using tetrazolium salts |
| US6420128B1 (en) * | 2000-09-12 | 2002-07-16 | Lifescan, Inc. | Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same |
| WO2002022854A2 (en) * | 2000-09-13 | 2002-03-21 | Merck Patent Gmbh | Method for the detection and measurement of biomass |
| US7524872B2 (en) * | 2000-09-15 | 2009-04-28 | Qingzhong Kong | Method and composition for treating cancer using cellular organelle crystallizing agents |
| RU2198402C2 (ru) * | 2001-03-11 | 2003-02-10 | ГУ Тверская государственная медицинская академия | Способ диагностики сахарного диабета |
| EP1828407B1 (en) * | 2004-12-17 | 2009-02-18 | Megazyme IP Limited | Assay for determination of free d-galactose and/or l-arabinose |
| WO2006064488A1 (en) * | 2004-12-17 | 2006-06-22 | Megazyme Ip Limited | A kit for colorimetric assays of food and beverage analytes |
| KR20070107786A (ko) * | 2005-02-22 | 2007-11-07 | 바이엘 헬쓰케어, 엘엘씨 | 측정기에 대한 마커의 아이콘 표시 |
| KR100793852B1 (ko) * | 2005-03-21 | 2008-01-11 | 김영기 | 착즙주스기 |
| KR100776914B1 (ko) | 2005-06-14 | 2007-11-15 | 주식회사 엘지화학 | 온도 측정 장치 |
| RU2394648C2 (ru) * | 2005-08-31 | 2010-07-20 | Эгомедикаль Технологиз Аг | Тест-система коагуляции |
| RU2398235C2 (ru) * | 2005-08-31 | 2010-08-27 | Эгомедикаль Технологиз Аг | Тест-система с использованием элементов неэнзиматического распознавания анализируемого вещества |
| WO2008030154A1 (en) * | 2006-09-08 | 2008-03-13 | Hemocue Ab | Haemolysing agent |
| US8008037B2 (en) * | 2008-03-27 | 2011-08-30 | Roche Diagnostics Operations, Inc. | Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline |
| KR101239381B1 (ko) * | 2012-05-02 | 2013-03-05 | 주식회사 아이센스 | 산화환원반응용 시약의 안정제 조성물 |
| CN103088108A (zh) * | 2012-11-16 | 2013-05-08 | 李立和 | 葡萄糖脱氢酶法检测葡萄糖的试剂盒及制备方法 |
| US9347958B2 (en) | 2014-06-27 | 2016-05-24 | Hemocue Ab | Device and method for determination of an analyte in blood |
| CN106018297A (zh) * | 2016-05-20 | 2016-10-12 | 大连大学 | 蓝莓中总黄酚含量的测定 |
| CN106018296A (zh) * | 2016-05-20 | 2016-10-12 | 大连大学 | 蓝莓中总黄酮含量的测定 |
| CN110715923A (zh) * | 2019-11-24 | 2020-01-21 | 天津市宝坻区人民医院 | α-D-葡萄糖检测试剂盒 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS164231B2 (sv) * | 1972-09-28 | 1975-11-07 | ||
| DE2349819A1 (de) * | 1973-10-04 | 1975-04-17 | Eppendorf Geraetebau Netheler | Verfahren zur enzymkinetischen konzentrationsbestimmung eines substrats |
| US4120755A (en) * | 1977-04-28 | 1978-10-17 | Beckman Instruments, Inc. | Kinetic method for determination of glucose concentrations with glucose dehydrogenase |
| US4975367A (en) * | 1986-04-04 | 1990-12-04 | Miles Inc. | Catalytic test composition intended to produce a range of colors |
| US4898813A (en) * | 1986-04-04 | 1990-02-06 | Albarella James P | Catalytic test composition intended to produce a range of colors |
| US5059394A (en) * | 1986-08-13 | 1991-10-22 | Lifescan, Inc. | Analytical device for the automated determination of analytes in fluids |
-
1989
- 1989-04-25 SE SE8901515A patent/SE466158B/sv not_active IP Right Cessation
-
1990
- 1990-04-24 AU AU55575/90A patent/AU637612B2/en not_active Ceased
- 1990-04-24 ES ES90908121T patent/ES2071821T3/es not_active Expired - Lifetime
- 1990-04-24 JP JP2507031A patent/JPH0734757B2/ja not_active Expired - Fee Related
- 1990-04-24 AT AT90908121T patent/ATE122102T1/de not_active IP Right Cessation
- 1990-04-24 KR KR1019910701447A patent/KR960001139B1/ko not_active Expired - Fee Related
- 1990-04-24 US US07/768,249 patent/US5278047A/en not_active Expired - Lifetime
- 1990-04-24 CA CA002053315A patent/CA2053315C/en not_active Expired - Lifetime
- 1990-04-24 RU SU905010235A patent/RU2050546C1/ru active
- 1990-04-24 WO PCT/SE1990/000272 patent/WO1990012889A1/en not_active Ceased
- 1990-04-24 DE DE69019149T patent/DE69019149T2/de not_active Expired - Lifetime
- 1990-04-24 EP EP90908121A patent/EP0470201B1/en not_active Expired - Lifetime
- 1990-04-24 BR BR909007339A patent/BR9007339A/pt not_active IP Right Cessation
- 1990-04-24 DK DK90908121.8T patent/DK0470201T3/da active
-
1991
- 1991-10-24 NO NO914181A patent/NO300853B1/no not_active IP Right Cessation
- 1991-10-24 FI FI915020A patent/FI97551C/sv active
-
1992
- 1992-12-17 LV LVP-92-308A patent/LV10122B/en unknown
- 1992-12-30 LT LTIP275A patent/LT3136B/lt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR960001139B1 (ko) | 1996-01-19 |
| KR920701476A (ko) | 1992-08-11 |
| LV10122A (lv) | 1994-05-10 |
| SE8901515D0 (sv) | 1989-04-25 |
| ATE122102T1 (de) | 1995-05-15 |
| AU637612B2 (en) | 1993-06-03 |
| JPH04504661A (ja) | 1992-08-20 |
| NO914181L (no) | 1991-10-24 |
| WO1990012889A1 (en) | 1990-11-01 |
| AU5557590A (en) | 1990-11-16 |
| FI97551C (sv) | 1997-01-10 |
| JPH0734757B2 (ja) | 1995-04-19 |
| FI915020A0 (sv) | 1991-10-24 |
| RU2050546C1 (ru) | 1995-12-20 |
| EP0470201B1 (en) | 1995-05-03 |
| US5278047A (en) | 1994-01-11 |
| BR9007339A (pt) | 1992-04-28 |
| CA2053315C (en) | 2000-07-04 |
| DE69019149D1 (de) | 1995-06-08 |
| CA2053315A1 (en) | 1990-10-26 |
| DK0470201T3 (da) | 1995-07-17 |
| ES2071821T3 (es) | 1995-07-01 |
| NO914181D0 (no) | 1991-10-24 |
| LT3136B (en) | 1995-01-31 |
| DE69019149T2 (de) | 1995-09-07 |
| SE466158B (sv) | 1992-01-07 |
| EP0470201A1 (en) | 1992-02-12 |
| NO300853B1 (no) | 1997-08-04 |
| LTIP275A (en) | 1994-07-15 |
| LV10122B (en) | 1995-02-20 |
| SE8901515L (sv) | 1990-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI97551B (sv) | Analysmetod, reagenskomposition och användning därav för glukosbestämning | |
| ES2288906T3 (es) | Pareja de colorantes para la determinacion espectrofotometrica de analitos. | |
| RU2052819C1 (ru) | Способ определения электрононасыщенного ароматического амина, являющегося маркером содержания аналита в биологической жидкости, и средство для его осуществления | |
| CN1207393C (zh) | 用于分析物测定的试剂测试条带 | |
| Campanella et al. | New biosensor for superoxide radical used to evidence molecules of biomedical and pharmaceutical interest having radical scavenging properties | |
| Wangsa et al. | Fiber-optic biosensors based on the fluorometric detection of reduced nicotinamide adenine dinucleotide | |
| US5156947A (en) | Process for reduction of the matrix effect in a fructosamine determination assay | |
| JP2003232789A (ja) | 安定化したテトラゾリウム試薬組成物およびこれを使用するための方法 | |
| FI81120B (fi) | Foerfarande foer bestaemning av glukos ur biologiska vaetska samt reagensblandning foer tillaempning av foerfarandet. | |
| US5312759A (en) | Method for measurement of fructosamines using 1,2-quinones | |
| JPS59162899A (ja) | β‐ヒドロキシ酪酸の定量用組成物 | |
| JP2005118014A (ja) | 分析方法およびそれに用いる試薬 | |
| JPH0365760B2 (sv) | ||
| JPH0532040B2 (sv) | ||
| EP0586397A4 (en) | IMPROVED METHOD AND REAGENT FOR DETERMINING AN ANALYTE. | |
| Chaichi et al. | Glucose chemiluminescence biosensor based on covalent immobilization of enzyme in glutaraldehyde-functionalized glass cell and direct coupling of chitosan-induced Au/Ag alloy nanoparticles | |
| JP4544598B2 (ja) | 液状試薬および保存方法 | |
| JP3869601B2 (ja) | ホモシステインの測定方法 | |
| JP2885864B2 (ja) | シアル酸の定量法 | |
| JP3186911B2 (ja) | 微量成分の定量方法 | |
| JPH0640098B2 (ja) | 試験手段の製造方法 | |
| JPH0772157A (ja) | 糖化蛋白の定量方法およびその定量用キット | |
| JP2001161399A (ja) | ホモシステインの定量方法並びにその試薬 | |
| JP2004037431A (ja) | 臨床検体の測定における共存物質の影響阻止方法 | |
| JPH0536038B2 (sv) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application |